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Curcuminoids are well-known for their therapeutic properties. However, their extraction
from natural sources is environmentally unfriendly, expensive and limited by seasonal
variability, highlighting the need for alternative production processes. We propose an
optimized artificial biosynthetic pathway to produce curcuminoids, including curcumin,
in Escherichia coli. This pathway involves six enzymes, tyrosine ammonia lyase
(TAL), 4-coumarate 3-hydroxylase (C3H), caffeic acid O-methyltransferase (COMT),
4-coumarate-CoA ligase (4CL), diketide-CoA synthase (DCS), and curcumin synthase
(CURS1). Curcuminoids pathway was divided in two modules, the first module included
TAL, C3H and COMT and the second one 4CL, DCS and CURS1. Optimizing the first
module of the pathway, from tyrosine to ferulic acid, enabled obtaining the highest
ferulic acid titer reported so far (1325.1 µM). Afterward, ferulic acid was used as
substrate to optimize the second module of the pathway. We achieved the highest
concentration of curcumin ever reported (1529.5 µM), corresponding to a 59.4%
increase. Subsequently, curcumin and other curcuminoids were produced from tyrosine
(using the whole pathway) in mono-culture. The production increased comparing to
a previously reported pathway that used a caffeoyl-CoA O-methyltransferase enzyme
(to convert caffeoyl-CoA to feruloyl-CoA) instead of COMT (to convert caffeic to ferulic
acid). Additionally, the potential of a co-culture approach was evaluated to further
improve curcuminoids production by reducing cells metabolic burden. We used one
E. coli strain able to convert tyrosine to ferulic acid and another able to convert the
hydroxycinnamic acids produced by the first one to curcuminoids. The co-culture
strategies tested led to 6.6 times increase of total curcuminoids (125.8 µM) when
compared to the mono-culture system. The curcuminoids production achieved in this
study corresponds to a 6817% improvement. In addition, by using an inoculation
ratio of 2:1, although total curcuminoids production decreased, curcumin production
was enhanced and reached 43.2 µM, corresponding to an improvement of 160%
comparing to mono-culture system. To our knowledge, these values correspond to
the highest titers of curcuminoids obtained to date. These results demonstrate the
enormous potential of modular co-culture engineering to produce curcumin, and other
curcuminoids, from tyrosine.
Keywords: curcuminoids, biosynthesis, E. coli, caffeic acid O-methyltransferase, co-culture engineering,
biosynthetic pathway
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INTRODUCTION
Curcuminoids are natural phenylpropanoids extracted from
the plant Curcuma longa that have innumerous therapeutic
properties including antioxidant (Wang et al., 2019), anti-
inflammatory (Dai et al., 2018), anticancer (Murray-Stewart
et al., 2018; Ravindranathan et al., 2018), and cholesterol-
lowering (Ferguson et al., 2018). They have also been reported as
protective agents for several neurodegenerative diseases (Maiti
and Dunbar, 2018). Curcumin, the curcuminoid that exhibits
the highest biological activity, holds an estimated market size
of USD 133 million by 2025 (Value Market Research, 2019).
Different curcuminoids have different therapeutic properties,
therefore being important to assess their individual bioactivity
as pure compounds. However, they have been mainly isolated
from turmeric in low amounts as a mixture of curcumin,
demethoxycurcumin, bisdemethoxycurcumin, and other
curcuminoids. Pure curcuminoids are very expensive and rare.
Besides low purity, the plant extraction also presents other
disadvantages such as long periods of growth and seasonal
variations. Thus, cost-effective and environmentally friendly
methods to obtain pure curcuminoids ought to be developed.
In the past decade, several efforts have been made to produce
curcuminoids using synthetic biology and metabolic engineering
approaches (Katsuyama et al., 2008, 2010; Wang et al., 2013,
2015; Rodrigues et al., 2015b,c, 2017; Couto et al., 2017; Kim
et al., 2017; Fang et al., 2018; Kang et al., 2018; Kan et al., 2019).
Curcuminoids have been produced intracellularly in Escherichia
coli host according to the biosynthetic pathway in Figure 1.
The curcumin biosynthetic pathway is complex requiring the
overexpression of six genes from plant, bacterial and fungal
sources. First, tyrosine is converted to coumaric acid by tyrosine
ammonia lyase (TAL). Afterward, caffeic acid is produced from
coumaric acid by 4-coumarate 3-hydroxylase (C3H). Then, two
different approaches can be used. The enzyme 4-coumarate-CoA
ligase (4CL) can convert caffeic acid to caffeoyl-CoA, and
caffeoyl-CoA O-methyl transferase (CCoAOMT) (Rodrigues
et al., 2015b) converts caffeoyl-CoA to feruloyl-CoA. In the
other approach, caffeic acid is converted to ferulic acid by caffeic
acid O-methyltransferase (COMT) and then to feruloyl-CoA by
4CL (Wang et al., 2015; Kang et al., 2018). Next, two molecules
of feruloyl-CoA and one of malonyl-CoA are converted to
curcumin by diketide-CoA synthase (DCS) and curcumin
synthase (CURS1) from C. longa or by curcuminoid synthase
(CUS) from Oryza sativa. Since 4CL, DCS, CURS1, and CUS
present broad substrate specificity (Rodrigues et al., 2015b,c),
FIGURE 1 | Curcuminoids biosynthetic pathway constructed in E. coli. Two molecules of CoA esters (coumaroyl-CoA or/and feruloyl-CoA) and one molecule of
malonyl-CoA are needed to produce one molecule of curcuminoid (bisdemethoxycurcumin, demethoxycurcumin or curcumin). TAL, tyrosine ammonia lyase; C3H,
4-coumarate 3-hydroxylase; COMT, caffeic acid O-methyltransferase; CCoAOMT, caffeoyl-CoA O-methyltransferase; 4CL, 4-coumarate-CoA ligase; DCS,
diketide-CoA synthase; CURS, curcumin synthase. Adapted from Rodrigues et al. (2015b).
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other curcuminoids are also produced. The highest curcumin
concentration reported previously using ferulic acid as substrate
was 959.3 µM (353.4 mg/L) at a yield of 95.9% (Couto et al.,
2017). However, curcumin production from tyrosine only
reached up to 0.6 mg/L (Wang et al., 2015). Recently, the
curcumin biosynthetic pathway was inserted in the E. coli
genome and 3.8 mg/L of curcumin were produced from glucose
using 4CL and DCS enzymes with mutations that confer
lower translation efficiencies (Kang et al., 2018). Despite this
improvement, the curcumin/curcuminoids biosynthetic pathway
still needs to be optimized to further increase the titers.
In this study, we did a step-by-step optimization of
the curcumin biosynthetic pathway. We started by dividing
the pathway in two modules. The first one contained the
genes of the pathway that converted tyrosine to ferulic acid.
The second module contained the genes that converted the
hydroxycinnamic acids to curcuminoids. The modules were
optimized separately. The highest ferulic acid production
achieved was 1325.1 µM (257.3 mg/L) and corresponded to
the highest production obtained to date. The second module
of the pathway was optimized by feeding ferulic acid to
produce curcumin. The curcumin concentration was improved
to 1529.5 µM (563.4 mg/L), the highest production achieved
until now. When the complete pathway was assembled in one
strain (monoculture system), the total curcuminoids (19.0 µM;
6.87 mg/L) and curcumin (16.6 µM; 6.1 mg/L) production from
tyrosine also increased compared to the production obtained
in previous studies (Rodrigues et al., 2015b; Wang et al.,
2015). However, it was still very low, mainly due to the
metabolic burden caused by the overexpression of the six genes
of the biosynthetic pathway. Recently, the use of co-culture
engineering, where two strains carry different modules of the
biosynthetic pathways, proved to improve the production of
several natural compounds (Jones et al., 2017; Li et al., 2019),
including curcuminoids (Fang et al., 2018). Therefore, a co-
culture system that allow a cascade conversion of tyrosine to
curcuminoids was tested, where an E. coli strain carrying the
first module of the pathway (TAL, C3H, and COMT genes)
produced hydroxycinnamic acids that another E. coli strain
carrying the other three genes of the pathway (4CL, DCS, and
CURS1 genes) was able to convert to curcuminoids. In the
co-culture system, the production of total curcuminoids from
tyrosine was 125.8 µM (41.5 mg/L). When a ratio of 2:1 (first
module of the pathway: second module of the pathway) was used
in the co-culture experiment, the curcumin production reached
43.2 µM (15.9 mg/L), i.e., the highest concentration obtained
so far. Regarding the mono-culture system, the production
of total curcuminoids and curcumin increased 6.6 and 2.6
times, respectively.
MATERIALS AND METHODS
Strains, Plasmids, and Chemicals
E. coli NZY5α competent cells (NZYTech, Lisbon, Portugal)
were used for molecular cloning and vector propagation
and E. coli BL21 (DE3) (NZYTech) was used as host for
expression of the biosynthetic pathway. Table 1 summarizes the
characteristics of all strains and plasmids used. Synthesis and
amplification of TAL, C3H, 4CL1, DCS, and CURS1 genes, as
well as plasmid construction with these genes was previously
described (Rodrigues et al., 2015a,b). pAC-4CL1 plasmid was
kindly provided by Claudia Schmidt-Dannert (Watts et al.,
2006) (Addgene plasmid # 35947). The plasmids pCas9Cr4
(Addgene plasmid #62655) and pKDsgRNA-p15A (Addgene
plasmid #62656) were kindly provided by Kristala Prather
(Reisch and Prather, 2015).
Tyrosine, coumaric and caffeic acid were purchased
from Sigma-Aldrich (Steinheim, Germany), ferulic acid
from Acros (Geel, Belgium), curcumin from Thermo
Fisher Scientific (Loughborough, United Kingdom), and
bisdemethoxycurcumin and demethoxycurcumin from
Abcam (Cambridge, United Kingdom). Isopropyl β-D-1-
thiogalactopyranoside (IPTG), super optimal broth with
catabolite repression (SOC), 5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside (X-Gal), and lysogeny broth (LB) medium
were purchased from NZYTech. Glucose (Acros), Na2HPO4
(Scharlau, Sentmenat, Spain), MgSO4, KH2PO4 (Riel-deHaën,
Seelze, Germany), methionine, NH4Cl, NaCl, CaCO3 (Panreac,
Barcelona, Spain) and thiamine (Thermo Fisher Scientific,
Loughborough, United Kingdom) were used to prepare the M9
modified salt medium. The following mineral traces and vitamins
were supplemented to M9 Medium: FeCl3, ZnCl2, CoCl2, CuCl2,
nicotinic acid (Riedel-deHaën), NaMoO4, H2BO3, pyridoxine,
biotin, folic acid (Merck), riboflavin, and pantothenic acid
(Sigma Aldrich). Ampicillin (AppliChem, Darmstadt, Germany),
chloramphenicol, kanamycin (NZYTech), spectinomycin
(Panreac), anhydrotetracycline (aTc), and arabinose (Acros) were
used whenever necessary.
Construction of Plasmids Carrying the
Biosynthetic Pathway
The 4CL gene was removed from pAC plasmid using XbaI and
NotI restriction enzymes. COMT gene from Arabidopsis thaliana
(GenBank accession numbers AY062837.1) was codon-optimized
and synthesized by NZYTech. The DNA sequence of the codon-
optimized gene is provided in Supplementary Table S1.
Afterward, COMT gene was cloned in pAC, pACYCduet-1
and pRSFduet-1. 4CL gene was amplified from pAC_4CL and
cloned in pACYCduet-1. Later, for monoculture and co-culture
experiments, other plasmids were also constructed. COMT
gene was amplified by PCR and cloned in pRSFduet_CURS1
and pRSFduet_C3H, 4CL gene in pRSFduet_CURS1, C3H
gene in pRSFduet_TAL and pCDFduet_DCS, TAL gene in
pACYCduet_4CL and DCS gene in pRSFduet_CURS1. All
the plasmids used in this study are presented in Table 1
and the primers (Metabion, Steinkirchen, Germany) in
Supplementary Table S2.
Plasmid DNA was isolated using NucleoSpin R© Plasmid
Miniprep Kit (Macherey-Nagel, Düren, Germany). The genes
were amplified by PCR using Phusion High Fidelity DNA
Polymerase (Thermo Fisher Scientific, Wilmington, DE,
United States). DNA fragments were purified from agarose using
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TABLE 1 | Bacterial strains and plasmids used in this study.
Strains Relevant genotype Source
E. coli NZY5α fhuA21(argF− lacZ)U169 phoA glnV44880 1(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17 NZYTech (MB00401)
E. coli BL21(DE3) F− ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 ∗ lacI lacUV5-T7 gene 1 ind1 sam7 nin5]) NZYTech (MB006)
E. coli BL21(DE3) 1lacZ F− ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 ∗ lacI lacUV5-T7 gene 1 ind1 sam7 nin5]) 1lacZ This study
Plasmids Construct Source
pCas9Cr4 p15A ori, Cas9 from Streptococcus pyogenes under control of PTET , constitutive tetR, CmR Addgene (62655)
pKDsgRNA-p15A SC101 ori, sgRNA targeting p15A ori under control of PTET ,λred under control of ParaB, araC, SpecR Addgene (62656)
pKDsgRNA-LacZ pKDsgRNA-p15A with sgRNA targeting lacZ instead of p15A ori This study
pRSFduet-1 RSF1030 ori, lacI, double PT7 lac, KanR Novagen
pACYCduet-1 p15A ori, lacI, double PT7 lac, CmR Novagen
pUC57_COMT pMB1 ori, AmpR; pUC57 carrying codon-optimized COMT from Arabidopsis thaliana NZYTech
pRSFduet_TAL pRSFduet-1 carrying codon-optimized TAL from Rhodotorula glutinis Rodrigues et al., 2015a
pCDFduet_TAL CloDF13 ori, lacI, double PT7 lac, StrepR; pCDFduet-1 carrying TAL Rodrigues et al., 2015a
pETduet_TAL ColE1(pBR322) ori, lacI, double PT7 lac, AmpR; pETduet-1 carrying TAL Rodrigues et al., 2015a
pETduet_TAL_C3H pETduet_TAL carrying codon-optimized C3H from Saccharothrix espanaensis Rodrigues et al., 2015a
pRSFduet_C3H pRSFduet-1 carrying C3H Rodrigues et al., 2015a
pCDFduet_C3H CloDF13 ori, lacI, double PT7 lac, StrepR; pCDFduet-1 carrying C3H Rodrigues et al., 2015a
pCDFduet_DCS CloDF13 ori, lacI, double PT7 lac, StrepR; pCDFduet-1 carrying codon-optimized DCS from Curcuma longa Rodrigues et al., 2015b
pRSFduet_CURS1 pRSFduet-1 carrying codon-optimized CURS1 from C. longa Rodrigues et al., 2015b
pRSFduet_CURS1_CCoAOMT pRSFduet_CURS1 carrying codon-optimized CCoAOMT from Medicago sativa Rodrigues et al., 2015b
pAC-4CL1 p15A ori, Plac, CmR, pACYC184-derived plasmid carrying 4CL1 from A. thaliana Addgene (35947)
pACYCduet_COMT pACYCDuet-1 carrying COMT This study
pRSFduet_COMT pRSFduet-1 carrying COMT This study
pAC_COMT pAC-4CL1 without 4CL1 and carrying COMT This study
pACYCduet_4CL1 pACYCduet-1 carrying 4CL1 This study
pRSFduet_CURS1_COMT pRSFduet_CURS1 carrying COMT This study
pCDFduet_DCS_C3H pCDFduet_DCS carrying C3H This study
pACYCduet_4CL1_TAL pACYCduet_4CL1 carrying TAL This study
pRSFduet_COMT_C3H pRSFduet_COMT carrying C3H This study
pRSFduet_CURS1_4CL1 pRSFduet_CURS1 carrying COMT This study
pRSFduet_CURS1_DCS pRSFduet_CURS1 carrying DCS This study
pRSFduet_TAL_C3H pRSFduet_TAL carrying C3H This study
NucleoSpin R© Gel and PCR Clean-up Kit (Macherey-Nagel).
Plasmid DNA and genes were quantified in a NanoDrop
instrument (ND-1000, Thermo Fisher Scientific) and were
digested with the appropriate restriction endonucleases
(Supplementary Table S2) (Thermo Fisher Scientific) for 3 h and
purified using NucleoSpin R© Gel and PCR Clean-up Kit. Ligation
was performed at room temperature for 1 h with T4 DNA ligase
(Thermo Fisher Scientific). Chemical transformation (heat shock
method) was carried out using E. coli NZY5α competent cells. All
constructed plasmids herein described were verified by colony
PCR and digestion and further confirmed by sequencing (GATC
Biotech, Konstanz, Germany). After confirmation, E. coli BL21
(DE3) competent cells were transformed with the constructed
plasmids. All the kits and enzymes were used according to the
instructions provided by the manufacturers.
Protein Analysis
E. coli BL21 (DE3) cells harboring pRSFduet-1, pRSFduet_
COMT, pACYCduet_COMT, and pAC_COMT were grown in
LB at 37◦C to an OD600 of 0.9. IPTG was added (at a final
concentration of 1 mM) to induce protein expression, and
the culture was incubated for 6 h. Samples (10 mL culture
medium) were taken at time 0 and 6 h of induction. Samples
were centrifuged and the cells were resuspended in Tris–HCl
buffer (1 mM, pH 7.8) and were further mechanically disrupted
using 1 mm glass beads (Sigma-Aldrich) and FastPrep-24 (MP
Biomedicals, Salon, OH, United States) (three cycles at speed
6 m/s for 1 min, 5 min cooling on ice after each cycle). After
centrifugation, the protein concentration of soluble and insoluble
fractions was determined using Pierce Coomassie (Bradford)
Protein Assay Kit according to the manufacturers’ instructions.
The expression levels of COMT were evaluated through sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS–PAGE)
(4% stacking gel and 10% running gel). Samples containing
soluble or insoluble protein fraction were mixed with 2× sample
buffer (65.8 mM Tris–HCl pH 6.8, 2.1% SDS, 26.3% glycerol,
0.01% bromophenol blue) and β-mercaptoethanol and were
denatured in a heating block at 100◦C for 5 min. The protein
marker used Color Protein Standard – Broad Range (NEB). After
electrophoresis, the gel was stained using Coomassie Blue R-250
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for 15 min and de-stained using distilled water until a clear
background was achieved.
Construction of a lacZ Disrupted E. coli
Strain
The disruption of lacZ from E. coli BL21 (DE3) was based
on methods previously described using clustered regulatory
interspaced short palindromic repeats – associated caspase 9
endonuclease (CRISPR-Cas9) (Reisch and Prather, 2015; Chung
et al., 2017). Plasmid pKDsgRNA-lacZ includes a protospacer
described by Chung et al. (2017) and was constructed using
circular polymerase extension cloning (Reisch and Prather,
2015). The primers used are presented in Supplementary
Table S3. The donor DNA (single strand) (Supplementary
Table S4) was synthesized by Metabion and corresponds to two
homology arms of 50 nt complementary to the E. coli BL21 (DE3)
genome. The homology arms were homologous to the upstream
region (−53 to −3 bp) and to the intergenic region of lacZ
(1516–1566 bp) as in Chung et al. (2017).
The plasmids pCas9Cr4 and pKDsgRNA-lacZ were
sequentially transformed in E. coli BL21 (DE3). The resultant
strain was cultured in LB medium (10 g/L tryptone, 5 g/L yeast
extract, 10 g/L NaCl) containing 25 µg/mL chloramphenicol
and 50 µg/mL spectinomycin at 30◦C (200 rpm). When optical
density at 600 nm (OD600) was between 0.35 and 0.5, arabinose
(1.2% (w/v) final concentration) was added to the medium to
induce the λ-Red recombinase and the culture was incubated
at 30◦C for more 20 min. Afterward, electrocompetent cells
were prepared and 10 µM donor DNA was transformed by
electroporation. The cells were plated in LB agar containing
chloramphenicol, spectinomycin, aTc (100 ng/mL), X-Gal
(0.1 mg/mL) and IPTG (1 mM) and grew overnight at 30◦C.
The white colonies containing the disruption were selected, and
the deletion was confirmed by colony PCR (Supplementary
Table S5). The selected mutant strain was cultured at 37◦C
to cure pKDsgRNA-lacZ that has a temperature-sensitive
replication origin. Then, pKDsgRNA-p15A was transformed
into E. coli BL21 (DE3) 1lacZ containing pCas9Cr4. After
transformation, the cells were recovered in SOC (20 g/L
tryptone, 5 g/L yeast extract, 3.6 g/L glucose, 0.186 g/L KCl,
0.5 g/L NaCl, 0.96 g/L MgCl2) containing aTc (100 ng/mL)
for 2 h and plated in LB containing spectinomycin and aTc
at 30◦C overnight to induce the curing of pCas9Cr4. After
confirming that the plasmid was cured, the cells were cultured
at 37◦C in order to cure pKDsgRNA-p15A. Finally, the mutant
strain (E. coli BL21 [DE3] 1lacZ) was transformed with the
two plasmids containing the second module of the biosynthetic
pathway (pCDFduet_DCS + pRSFduet_CURS1_4CL or
pACYCduet_4CL + pRSFduet_CURS1_DCS) and used in
co-culture systems.
Ferulic Acid and Curcuminoids
Production
E. coli cells for plasmid propagation and inoculum preparation
were grown in LB medium at 37◦C and under shaking
conditions (200 rpm).
For hydroxycinnamic acids and curcuminoids production,
cultures were grown at 37◦C in 50 mL LB from an OD600 of 0.1
(≈2% inoculum volume) up to 0.9. In the co-culture experiments,
the different strains (with different modules of the pathway)
were separately cultivated in LB medium and these overnight
cultures were then used to inoculate the co-culture experiment
in LB with different inoculation ratios (≈2% inoculum volume
for all the tested ratios – 1:1, 2:1, 1:2). All the experiments
(mono-culture and co-culture) were performed with E. coli BL21
(DE3) excluding the co-cultures system experiments where each
strain carried two instead of three plasmids. In these specific
experiments E. coli BL21 (DE3) carried the first module of the
pathway and E. coli BL21 (DE3) 1lacZ carried the second one.
After reaching the target OD600, the protein expression was
induced with IPTG (0.1 mM) and the culture was then incubated
for 5 h at 26◦C. Next, the cells were harvested by centrifugation,
suspended, and incubated at 26◦C for 63 h in 50 mL M9 medium.
Tyrosine (3 mM), caffeic acid (1 mM) or ferulic acid (2 mM) and
IPTG (0.1 mM) were added at time 0 of induction in modified
M9 medium. The experiments occurred during 63 h after adding
the substrate. In specified experiments ferulic acid (1 mM) was
also added at 15 h.
Modified M9 minimal salt medium contained (per liter): 40 g
glucose, 6 g Na2HPO4, 3 g KH2PO4, 1 g NH4Cl, 0.5 g NaCl, 15 mg
CaCl2, 110 mg MgSO4, 340 mg thiamine, 149.2 mg methionine,
and 5 g CaCO3. Trace elements (54 mg FeCl3, 4 mg ZnCl2,
4 mg CoCl2, 4 mg NaMoO4, 2 mg CuCl2, and 1 mg H2BO3)
and vitamins (0.84 mg riboflavin, 0.084 mg folic acid, 12.2 mg
nicotinic acid, 2.8 mg pyridoxine, 0.12 mg biotin, and 10.8 mg
pantothenic acid) were supplemented to the medium. Depending
on the plasmid(s) present in the strains, 100 µg/mL of ampicillin,
100 µg/mL of spectinomycin, 30 µg/mL of chloramphenicol
and/or 50 µg/mL of kanamycin were used.
All the experiments were conducted in triplicate. Supernatant
samples (1 mL) were collected for the analysis of coumaric,
caffeic, and ferulic acids, while for curcuminoids 200 µL to 2 mL
of culture broth with cells (whole broth) were collected.
Estimation of the Strain-to-Strain Ratio
in the Co-culture Systems
The strain-to-strain ratio in co-culture systems, where each
strain carried two plasmids, was analyzed using the blue-white
screening method and a method that relies on the production
of curcuminoids. Strain E. coli BL21 (DE3) contained the
first module of the pathway and E. coli BL21 (DE3) 1lacZ
contained the second module that produced curcuminoids from
hydroxycinnamic acids. During the co-culture fermentation,
10 µL samples were taken and diluted 50 to 100-fold. Afterward,
10 µL of the dilution were spread in LB agar plates containing
the required antibiotics, and 0.1 mg/mL X-Gal and 1 mM IPTG
(for the blue-white screening method) or 0.5 mM ferulic acid
and 1 mM IPTG (for curcuminoids production method). E. coli
with disrupted lacZ only formed white colonies in the presence
of X-gal while the other one formed blue colonies. In the other
method, E. coli containing the second module of the pathway,
in the presence of ferulic acid produced curcumin and generated
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yellow/orange colonies while the strain that contained the first
module formed white colonies. The number of colonies of each
color for each method were counted to estimate the strain-to-
strain ratio in the co-culture system. It should be noted that these
methods only allow to determine the ratio of viable cells.
Curcuminoids Extraction
Curcuminoids are mostly present inside E. coli cells. However,
when their production is very high, they can also be found in
the supernatant. Therefore, whole broth was mixed with an equal
volume of ethyl acetate (Thermo Fisher Scientific). The mixture
was vortexed and centrifuged (2 min, 15,000 × g). The aqueous
phase was transferred to a new tube and this process was repeated
until the pellet was not colored due to curcuminoids presence.
Finally, the extracts were concentrated by solvent evaporation
in a fume hood, suspended with at least 200 µL of acetonitrile
(Thermo Fisher Scientific) and subjected to product analysis by
ultra-high-performance liquid chromatography (UHPLC).
UHPLC Analysis
Ultra-high-performance liquid chromatography analysis was
used to quantify hydroxycinnamic acids (coumaric acid,
caffeic acid, and ferulic acid) and curcuminoids (curcumin,
bisdemethoxycurcumin, demethoxycurcumin) using the
Shimadzu Nexera-X2 system (Shimadzu Corporation, Kyoto,
Japan) (CBM-20A system controller, LC-30AD pump unit,
DGU-20A 5R degasser unit, SPD-M20A detector unit, SIL-
30AC autosampler unit, CTO-20AC column oven) and a
Kinetex R© 2.6 µm Polar C18 100 Å LC column (150 × 4.6 mm)
(Phenomenex, Alcobendas, Spain). Mobile phase A was
composed of 0.1% (v/v) of trifluoroacetic acid (Fluka) in
water and mobile phase B was composed of acetonitrile. For
hydroxycinnamic acids quantification, the following gradient
was used at a flow rate of 1 mL/min: 10–40% mobile phase B for
16 min, 40–70% for 1 min, 70–10% for 4 min, and 10% mobile
phase B for an additional 4 min. Quantification was based on the
peak areas at 310 nm for caffeic acid, coumaric acid and ferulic
acid and the retention time was 6.4, 8.5, and 9.2 min, respectively.
For curcuminoids quantification, a gradient of 40–43% mobile
phase B for 15 min and 43–70% for 3 min, 70–40% for 4 min
and 40% mobile phase B for an additional 5 min was used.
Curcuminoids were detected at 425 nm of absorbance and
the retention time was 12.1 min for bisdemethoxycurcumin,
13.2 min for demethoxycurcumin, and 14.3 min for curcumin.
RESULTS AND DISCUSSION
Rational Design and Production of
Ferulic Acid From Caffeic Acid Using
COMT From A. thaliana
Different enzymes can be used to produce curcumin from
tyrosine (Figure 1). In a previous study, 4CL was used to
produce caffeoyl-CoA from caffeic acid and CCoAOMT was
used to convert caffeoyl-CoA to feruloyl-CoA (Rodrigues et al.,
2015b). Although the production of caffeic acid as intermediate
in the curcuminoids pathway allowed to produce curcumin from
tyrosine for the first time, the production obtained was residual.
Since the initial steps of the biosynthetic pathway (from tyrosine
to caffeic acid) and the last steps of the pathway (from ferulic acid
to curcumin) were found to be very efficient, it was hypothesized
that the combination of 4CL and CCoAOMT was the main
bottleneck of the pathway. Therefore, in the newly designed
pathway a 4CL was used to convert ferulic acid to feruloyl-
CoA similarly to when curcumin was produced directly from
this substrate. 4CL, more specifically 4CL1 from A. thaliana,
although not reported to have higher affinity to ferulic acid
than to caffeic acid (Ehlting et al., 1999), when combined with
DCS and CURS1 was found to produce high concentrations
of curcumin from ferulic acid (Rodrigues et al., 2015b; Couto
et al., 2017). To further complete the pathway, it was important
to find an efficient enzyme to convert caffeic acid to ferulic
acid. COMT from A. thaliana was previously reported to be
very efficient in that conversion step (Choi et al., 2011; Kang
et al., 2012, 2015). Additionally, it has been reported to have
more activity toward caffeic acid compared to other COMT
enzymes recently characterized (Byeon et al., 2014; Dwivedi
et al., 2014; Wiens and De Luca, 2016). Therefore, COMT gene
from A. thaliana was herein codon-optimized and cloned into
three different plasmids. Methionine was added to M9 minimal
medium in order to increase the supply of S-adenosylmethionine,
the methyl donor required in methyltransferase reactions (Heo
et al., 2017). The production of ferulic acid from caffeic acid for
each case is illustrated in Figure 2. In two cases, COMT was
found to completely convert caffeic to ferulic acid (1 mM) and
this conversion was faster using pACYCduet_COMT compared
to pRSFduet_COMT. In the other case (pAC_COMT), the
production of ferulic acid only reached 0.23 mM most probably
due to the promoter used, i.e., the constitutive pLac, which is
weaker than the pT7lac one. The expression of COMT enzyme
was confirmed by SDS-PAGE (Supplementary Figure S1). As
expected, the expression was higher when pRSFduet-1 was used
followed by pACYCduet-1 and pAC.
Production of Ferulic Acid From Tyrosine
Using Different Combinations of
Plasmids – Module 1 of the Biosynthetic
Pathway
After studying the ferulic acid production from caffeic acid,
plasmids carrying the COMT gene were combined with
previously constructed plasmids carrying TAL and C3H genes
(Rodrigues et al., 2015a) to further evaluate the production of
ferulic acid from tyrosine (Figure 3). As previously reported
(Kang et al., 2012; Rodrigues et al., 2015a,b, 2017), coumaric acid
accumulates in very high concentrations since the beginning of
the fermentation while caffeic acid production is limited due to
the C3H catalytic efficiency. Regarding ferulic acid productions,
the plasmid combinations that included pAC_COMT led to
very low concentrations of ferulic acid and consequently, a
higher accumulation of caffeic acid in the culture medium was
found. The combination of plasmids with pRSFduet_COMT
led to a complete conversion of caffeic to ferulic acid. During
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FIGURE 2 | Production of ferulic acid from caffeic acid in E. coli BL21 (DE3) using different expression vectors. COMT, caffeic acid O-methyltransferase.
FIGURE 3 | Production of the three hydroxycinnamic acids (coumaric, caffeic, and ferulic acids) in E. coli BL21 (DE3) using tyrosine as substrate, after 63 h of
fermentation. TAL, tyrosine ammonia lyase; C3H, 4-coumarate 3-hydroxylase; COMT, caffeic acid O-methyltransferase.
the fermentation caffeic acid was never accumulated, it was
automatically converted to ferulic acid. However, the highest
ferulic acid titers were achieved when pACYCduet_COMT was
used. In the combination that includes pRSFduet_COMT, the
accumulation of coumaric acid was very high since the beginning
of the fermentation (at 15 h was 1.95 mM), while in the
cases where pACYCduet_COMT was present, the accumulation
was not that high (at 15 h was 0.809–0.889 mM) (data not
shown). This very high accumulation of the intermediate may be
not beneficial to the production of ferulic acid since coumaric
acid, and caffeic acid, are reported to be toxic to the cells
at high concentrations (Watts et al., 2006; Furuya and Kino,
2013; Huang et al., 2013; Zhang and Stephanopoulos, 2013;
Rodrigues et al., 2015a). Nevertheless, the highest ferulic acid
concentration obtained from tyrosine was 889 µM (172.6 mg/L).
This production is higher than the one reported by Wang et al.
(2015) (28.8 mg/L) using TAL and C3H from Saccharothrix
espanaensis and COMT from Medicago sativa. Other studies
using a tyrosine overproducing E. coli strain carrying TAL
and C3H from S. espanaensis and COMT from A. thaliana
reported ferulic acid titers in the same range of this study (123–
196 mg/L) (Kang et al., 2012, 2015). Indeed, the use of a tyrosine
overproducing strain can be an advantageous strategy not only
from an economic point of view, but also to improve ferulic acid
production without accumulating high amounts of intermediates
(coumaric and caffeic acid) as we observed in this study. The
engineering of aromatic carboxylic acids efflux pumps involved in
the excretion of hydroxycinnamic acids (such as aaeXAB operon)
can also increase E. coli tolerance to hydroxycinnamic acids
(Vargas-Tah and Gosset, 2015).
Production of Curcumin From Ferulic
Acid – Module 2 of the Biosynthetic
Pathway
The second module of the pathway (from ferulic acid
to curcumin) was also optimized. Previously, 4CL gene
was expressed in pAC plasmid (Wang et al., 2013;
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FIGURE 4 | Production of curcumin from ferulic acid in E. coli BL21 (DE3)
using different plasmids and conditions, after 63 h of fermentation.
pRSFduet_CURS1 and pCDFduet_DCS were combined with pAC_4CL (1,3)
or pACYCDuet_4CL (2,4). Ferulic acid was added at a concentration of 2 mM
at time 0 of induction in M9 (1–4) and 1 mM of ferulic acid was also added
after 15 h (3,4). 4CL, 4-coumarate-CoA ligase; DCS, diketide-CoA synthase;
CURS1, curcumin synthase 1.
Rodrigues et al., 2015b, 2017; Couto et al., 2017). However,
since pACYCduet plasmid allowed to obtained better results in
the production of ferulic acid than pAC (Figure 2), 4CL gene
was also cloned in pACYCduet. Afterward, pACYCduet_4CL
was combined with pCDFduet_DCS and pRSFduet_CURS1. As
can be observed in Figure 4, the curcumin production when
using pACYCduet_4CL instead of pAC_4CL improved but not
significantly as the yield was already around 100%. Therefore,
more ferulic acid (1 mM) was added at 15 h in both cases.
The extra ferulic acid was not added in the beginning of the
assay to avoid an unnecessary toxicity to the cells. A 20.9%
increase of curcumin production corresponding to 1212.7 µM
(446.7 mg/L), the highest concentration reported so far using
heterologous production, was obtained. Although we increased
the concentration of the starter substrate (ferulic acid), the cells
were not able to completely convert it to curcumin. A possible
reason for this is the low availability of the precursor malonyl-
CoA (Xu et al., 2012, 2013; Machado et al., 2014; Lv et al., 2019)
that is naturally synthesized in E. coli for the production of
fatty acids and phospholipids and that is also needed for the
production of curcuminoids (Figure 1). Therefore, in the future,
to achieve high concentrations of curcumin from ferulic acid it
will be important to also increase malonyl-CoA availability using
well-established methods (Xu et al., 2012, 2013; Rodrigues et al.,
2015c; Jones et al., 2017; Fang et al., 2018; Lv et al., 2019).
While curcumin (or other curcuminoids) production from
ferulic acid (or other hydroxycinnamic acids) is not our main
goal since this can be expensive at an industrial scale, it can
be necessary for some applications given that obtaining very
pure curcumin (or other curcuminoids) from plant extraction
or chemical synthesis is extremely difficult and/or expensive
(Friesen et al., 2019; Neven, 2019). Its heterologous production
from glucose to obtain high purities is also not possible yet,
mainly due to the involved enzymes (4CL, DCS, CURS1)
broad specificity. On the contrary, the direct addition of ferulic
acid (or other hydroxycinnamic acid) leads to the production
of pure curcumin (or other curcuminoid). Ultimately, these
pure compounds can be used, for example, to determine their
therapeutic activity either alone or in different combinations.
Curcuminoids Production by E. coli
Mono-Culture System – Whole
Biosynthetic Pathway
After optimizing both pathway modules, the production of
curcuminoids from caffeic acid and tyrosine (Figure 5) was
evaluated in a mono-culture system. For that purpose, the
COMT gene was cloned in the same plasmid of CURS1
gene similarly to what was previously done for CCoAOMT
(Rodrigues et al., 2015b) and the pETduet_TAL_C3H plasmid
was also combined. pETduet-1 plasmid carrying the genes of
interest (TAL and C3H) was chosen due to the compatible
antibiotic resistance and replication origin. In addition, the
pathway with pACYCduet_4CL was also tested with CCoAOMT.
The curcuminoids production using CCoAOMT was improved
comparing to the results previously reported (Rodrigues et al.,
2015b) probably not only due to the cloning of 4CL gene in
pACYCduet-1, but also to the use of a different host, E. coli BL21
(DE3) instead of E. coli K-12 (DE3). In a previous work we found
that E. coli BL21 (DE3) was a better host to produce curcumin
(Couto et al., 2017).
Comparing the results obtained when CCoAOMT was used
[Figure 5, experiments (1) and (3)] with the ones with COMT
[Figure 5, experiments (2) and (4)], it was found that COMT
enzyme leads to a higher curcumin (and other curcuminoids)
production. Curcumin production using COMT enzyme was 10.6
and 2.0 times higher than using CCoAOMT when caffeic acid
and tyrosine, respectively, were supplied. The pathway including
COMT instead of CCoAOMT possibly has an increased feruloyl-
CoA availability.
As expected, when caffeic acid (1 mM) was supplemented
to produce curcumin, its production (126.5 µM) decreased
significantly [Figure 5, experiment (2)] compared to the
production obtained when ferulic acid was supplemented directly
to the medium [Figure 4, experiment (2) – 1003 µM]. As can be
observed in Figure 5, ferulic acid was produced in low amounts.
When tyrosine was used as substrate the curcumin production
was even lower (2.2 µM–0.82 mg/L), indeed it decreased 57 times.
Even though, it was higher than the one reported by Wang et al.
(2015) (0.6 mg/L) using a similar pathway but with COMT from
M. sativa and CUS from O. sativa. The total concentration of
curcuminoids produced in these experiments (Figure 5) from
tyrosine was approximately 4.7 µM (1.7 mg/L).
Curcuminoids Production by E. coli
Co-culture System – Combination of
Module 1 and Module 2 of the
Biosynthetic Pathway
The decrease observed in the curcuminoids production by E. coli
mono-culture from tyrosine was predictable since, generally, as
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FIGURE 5 | Curcuminoids production in E. coli BL21 (DE3) (mono-culture) using caffeic acid (1, 2) and tyrosine (3,4) as substrates, after 63 h of fermentation. Two
different pathways were tested with two different enzymes, CCoAOMT (1,3) and COMT (2,4). TAL, tyrosine ammonia lyase; C3H, 4-coumarate 3-hydroxylase;
COMT, caffeic acid O-methyltransferase; CCoAOMT, caffeoyl-CoA O-methyltransferase; 4CL, 4-coumarate-CoA ligase; DCS, diketide-CoA synthase; CURS1,
curcumin synthase 1.
the complexity of the metabolic biosynthetic pathways increases,
the metabolic load to the cell increases resulting in lower
growth rates and productivity. However, the increase of pathway
complexity and its further optimization is of upmost importance
as feeding hydroxycinnamic acids to produce curcumin and/or
curcuminoids is not economically feasible. Curcuminoids
heterologous production will only reach industrial scale in the
future if simple carbon sources, such as glucose, can be used as
substrate by a tyrosine overproducing E. coli strain and if high
productions can be obtained. Therefore, in order to distribute
the metabolic burden and increase the production efficiency, a
co-culture strategy was designed. For this purpose, two E. coli
BL21 (DE3) strains were used, one carrying the pathway to
convert tyrosine to ferulic acid, and the other carrying the
second module of the pathway to convert ferulic acid (and/or
coumaric acid) to curcuminoids (Figure 6). For the first module
of the pathway, two strains that showed previously (Figure 3)
high production of ferulic acid were used – the strain carrying
pCDFduet_TAL, pRSFduet_C3H and pACYCduet_COMT
and the strain carrying pRSFduet_TAL, pCDFduet_C3H and
pACYCduet_COMT (Figure 7). These strains were combined
with one strain that carried pACYCduet_4CL, pCDFduet_DCS
and pRSFduet_CURS1 and these combinations are from now
on designated co-culture 1 and co-culture 2, respectively. Other
strains carrying other combinations of the first module of the
pathway (Figure 3) were not chosen for further experiments
since it was considered that the concentration of ferulic acid
that they produced was very low and therefore, not enough to
have significant titers of curcuminoids. Moreover, the strain
carrying pETduet_TAL, pCDFduet_C3H and pRSFduet_COMT
(Figure 3) was not chosen for further experiments since it
was not able to grow when combined with the strain that
carried the second module of the pathway due to selection
mark incompatibility.
The division of labor between the two strains allowed to
improve the production of curcuminoids. The highest curcumin
production with these co-culture strategies was 14.9 µM and this
was 6.8 times higher than the one achieved using the mono-
culture system [Figure 5, experiment (4)]. In addition, the total
curcuminoids production also increased 6.4 times. This type of
improvement was also observed by Fang et al. (2018) that used
co-culture engineering to produce bisdemethoxycurcumin.
Curcuminoids Production by
Mono-Culture and Co-culture Systems
After Reducing Metabolic Burden
Caused by Multiple Plasmids
Plasmid replication and maintenance imposes a metabolic
burden on the host cells since it takes over cell resources such
as carbon building blocks and energy molecules (adenosine
triphosphate, nicotinamide adenine dinucleotide, nicotinamide
adenine dinucleotide phosphate, among others). Reducing the
number of plasmids reduces the load to the cell and can
increase the productivity of the engineered strain. Since the
plasmids used in this study are Duet plasmids (have two multiple
cloning sites with two T7 promoters) (Novagen), another type
of experimental design could be evaluated. The mono-culture
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FIGURE 6 | Cascade conversion of tyrosine to curcuminoids using a co-culture system. One E. coli strain converts tyrosine to ferulic acid and the other one converts
ferulic acid and coumaric acid to different curcuminoids. TAL, tyrosine ammonia lyase; C3H, 4-coumarate 3-hydroxylase; COMT, caffeic acid O-methyltransferase;
4CL, 4-coumarate-CoA ligase; DCS, diketide-CoA synthase; CURS1, curcumin synthase.
system could be improved by cloning for instance TAL and
C3H genes in the plasmids containing 4CL and DCS genes,
reducing the number of plasmids used and, consequently, the
metabolic burden. Having this goal in mind, the necessary
cloning and experiments were performed. As can be observed
in Figure 8A, that gathers the mono-culture system results
after reducing the number of plasmids from four to three,
the curcuminoids production improved significantly. Using this
strategy, the curcumin production was 7.5 times higher than the
one obtained using four plasmids [Figure 5, experiment (4)].
This production (16.6 µM; 6.1 mg/L) was the highest production
obtained so far from tyrosine using mono-culture system. The
highest production of curcumin from tyrosine reported until now
was 0.6 mg/L by Wang et al. (2015). From Figure 8A, it is possible
to verify that the production of the other curcuminoids was very
similar to the one previously achieved [Figure 5, experiment (4)].
The other curcuminoids (bisdemethoxycurcumin and curcumin)
need coumaric acid accumulation to be further produced.
However, according to the results obtained, coumaric acid was
very efficiently converted to caffeic acid. Indeed, it was never
significantly accumulated during the 63 h (data not shown).
Co-culture systems might also be improved by decreasing
the number of plasmids used. Each strain may carry only two
plasmids with, for example, three genes reducing even more
the metabolic burden. From Figures 8B,C, it is possible
to observe the results achieved for each module of the
pathway. Two combinations of plasmids were tested for
each module. For the production of ferulic acid from tyrosine,
E. coli carrying pCDFduet_TAL and pRSFduet_C3H_COMT
was the one that allowed to obtain higher productions of
ferulic acid (1325.1 µM). When compared to the strategy
that produced more ferulic acid using three plasmids
(pRSFduet_TAL + pCDFDuet_C3H + pACYCduet_COMT)
(Figure 3), the production increased 49%, which is very
significant. This is by far the highest ferulic acid titer obtained
using tyrosine as substrate. This improvement is of interest for
all of those working in the production not only of curcuminoids
but other relevant compounds that are produced from ferulic
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acid such as coumarins, lignans, vanillin, among others. Using
the other combination of plasmids, ferulic acid production was
very low while caffeic acid reached a very high concentration
(1238.2 µM). This concentration is also higher than the ones
previously reported using C3H gene (Zhang and Stephanopoulos,
2013; Rodrigues et al., 2015a).
As previously mentioned, the design of the second module
of the pathway was also rethought (Figure 8C). To use
only two plasmids, 4CL and DCS genes were cloned in
pRSFduet_CURS1 and two combinations of plasmids were
tested, namely pCDFduet_DCS + pRSFduet_CURS1_4CL
and pACYCduet_4CL + pRSFduet_CURS1_DCS. These
combinations allowed to achieve very high concentrations
and yields of curcumin as when three plasmids were used
(Figure 4). However, when more substrate was added after 15 h,
the conversion of curcumin was significantly higher than the
one obtained previously with three plasmids. This reduction in
the metabolic burden allowed to obtain the highest curcumin
concentration reported to date, 1529.5 µM (563.4 mg/L), with
a percent yield of 100%. This shows that, at these levels of
curcumin production, contrary to what was hypothesized, the
precursor malonyl-CoA is not limitant.
After testing both modules of the pathway separately, the
complete pathway was tested using a co-culture system. In this
case, each E. coli carried a module of the pathway but with only
two plasmids instead of three as was presented in Figure 7. Using
the plasmids presented in Figures 8B,C, only two combinations
(named co-culture 3 and co-culture 4) could be tested since
for both strains to grow together they needed the same
antibiotic selection. Co-culture 3 contained pCDFduet_TAL and
pRSFduet_C3H_COMT in one E. coli and pCDFduet_DCS
and pRSFduet_CURS1_4CL in the other. Co-culture 4 was
composed by one E. coli carrying pRSFduet_TAL_C3H and
pACYCduet_COMT and another one carrying pACYCduet_4CL
and pRSFduet_CURS1_DCS. These co-cultures allowed to
produce higher concentrations of total curcuminoids than the
ones previously tested (Figure 7). Co-culture 3 was the one that
allowed to obtain higher production (125.8 µM). This production
was 6.6 and 4.2 times higher than the ones obtained with the
optimized mono-culture (Figure 8A) and with the other co-
cultures tested (Figure 7), respectively. However, the curcumin
production (17.1 µM) did not increase significantly. Coumaric
acid was highly accumulated in the beginning of the fermentation
(Supplementary Figure S2) leading to high productions of
bisdemethoxycurcumin, that is produced using two molecules of
coumaric acid. In co-culture 3 ferulic acid was not accumulated in
high amounts during fermentation and, consequently, curcumin
was not significantly produced. This was even more evident for
co-culture 4 that produced ferulic acid in even lower amounts
leading to only very high titers of demethoxycurcumin. It is very
important that the intermediates are highly accumulated since
the division of labor between the two strains may disrupt natural
channels and dilute the intermediate concentrations inside the
cell that uses it as substrate (Roell et al., 2019).
In these fermentations, the second module of the pathway
was inserted in a E. coli BL21 (DE3) strain with the lacZ gene
disrupted. This disruption does not allow the production of
β-galactosidase that converts X-Gal into a blue insoluble pigment.
Therefore, it is possible to distinguish both strains when X-Gal
is present – the strain carrying the second module forms white
colonies while the other one forms blue colonies (Zhang et al.,
2015; Li et al., 2019). By plating fermentation samples, it was
possible to estimate the strain-to-strain ratio in the co-cultures. In
parallel, the samples were also plated in medium with ferulic acid.
This also allowed to distinguish the strains through differences
in color (orange-yellow/white), but the colonies were more
difficult to distinguish, depending on the amount of curcumin
produced by each colony. Anyway, the results obtained through
the two methods were very consistent. Although the strains
were inoculated in the same proportion, it was observed that
after inducing the protein expression in LB with IPTG the
population started to change and after 5 h of induction the
FIGURE 7 | Curcuminoids production in co-culture experiments, after 63 h of fermentation. Each E. coli BL21 (DE3) carried a module of the pathway. The difference
between the two co-cultures was the first module. Co-culture 1 contained one E. coli carrying pCDFduet_TAL, pRSFduet_C3H and pACYCduet_COMT, and
co-culture 2 one E. coli carrying pRSFduet_TAL, pCDFduet_C3H and pACYCduet_COMT. The second module of the pathway was common to both co-cultures and
was composed of pACYCduet_4CL, pCDFduet_DCS and pRSFduet_CURS1. TAL, tyrosine ammonia lyase; C3H, 4-coumarate 3-hydroxylase; COMT, caffeic acid
O-methyltransferase; 4CL, 4-coumarate-CoA ligase; DCS, diketide-CoA synthase; CURS1, curcumin synthase 1.
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FIGURE 8 | Curcuminoids and hydroxycinnamic acids production by E. coli at 63 h after reducing the number of plasmids used. (A) Production of curcuminoids by
E. coli BL21 (DE3) mono-culture system from tyrosine and carrying pACYCduet_4CL_TAL, pCDFduet_DCS_C3H and pRSFduet_CURS1_COMT. (B) Production of
hydroxycinnamic acids by E. coli BL21 (DE3) from tyrosine and carrying pCDFduet_TAL and pRSFduet_C3H_COMT or pRSFduet_TAL_C3H and
pACYCduet_COMT. (C) Production of curcumin by E. coli BL21 (DE3) 1lacZ from ferulic acid and carrying pCDFduet_DCS and pRSFduet_CURS1_4CL or
pACYCduet_4CL and pRSFduet_CURS1_DCS. (D) Production of curcuminoids by co-culture system from tyrosine. In co-culture 3, E. coli BL21 (DE3) carried
pCDFuet_TAL and pRSFduet_C3H_COMT and E. coli BL21 (DE3) 1lacZ carried pCDFduet_DCS and pRSFduet_CURS1_4CL. In co-culture 4, E. coli BL21 (DE3)
carried pRSFduet_TAL_C3H and pACYCduet_COMT and E. coli BL21 (DE3) 1lacZ carried pACYCduet_4CL and pRSFduet_CURS1_DCS. Co-culture 3 was tested
using different inoculation ratios (1:1, 2:1 and 1:2). TAL, tyrosine ammonia lyase; C3H, 4-coumarate 3-hydroxylase; COMT, caffeic acid O-methyltransferase; 4CL,
4-coumarate-CoA ligase; DCS, diketide-CoA synthase; CURS1, curcumin synthase 1.
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ratio was 1.3%:98.7% (strain carrying first module: strain carrying
second module). This was not expected since both strains when
inoculated separately exhibited approximately the same growth
rate (≈0.8 h−1). However, this type of change in the ratio between
the co-culture strains was also previously observed by Li et al.
(2019) and is considered normal since both strains are competing
for the same carbon source. The balanced growth of the co-
cultures strains is very hard to maintain (Zhang and Wang, 2016).
From the results it is possible to conclude that the strain carrying
the first module of the pathway was at growth disadvantage.
After 24 h in M9 the population started to change and at 63 h
the proportion was around 20%: 80%. This change may be
justified by the accumulation of curcuminoids inside the strains
carrying the second module of the pathway. The accumulation
of curcuminoids may decrease the cells viability due to their
known antibacterial activity. In the future, the engineering of
transporter proteins to excrete curcuminoids to the extracellular
medium can be very valuable. Zhao et al. (2018) overexpressed
10 transport genes (multidrug efflux pump proteins, transporters
and outer membrane proteins) and almost doubled resveratrol
production. A similar approach can improve curcuminoids yield
by decreasing their toxicity to the cells.
The population behavior in co-culture motivated the study
of different inoculation ratios (1:2 and 2:1) of co-culture
3, the one that allowed higher production of curcuminoids
(Figure 8D). When the strain containing the first module
was inoculated at a lower ratio (1:2), the production of
hydroxycinnamic acids was very low during the fermentation
and the conversion of coumaric acid to caffeic acid and ferulic
acid was not very efficient. Therefore, bisdemethoxycurcumin
and demethoxycurcumin were the curcuminoids produced
in higher amounts. The total curcuminoids concentration
(98.9 µM) and proportion was not very different from the one
obtained for the ratio 1:1. However, when the strain containing
the first module of the pathway was present in a higher
percentage in the beginning of the fermentation (ratio 2:1) the
proportion of curcuminoids obtained was different. Curcumin
(43.2 µM) was the most produced curcuminoid followed
by demethoxycurcumin. Bisdemethoxycurcumin, that depends
exclusively on the coumaric acid availability was produced in
lower amounts because during fermentation coumaric acid was
efficiently converted to ferulic acid (Supplementary Figure S2).
Although this ratio (2:1) did not allow to increase the number
of total curcuminoids produced (76.0 µM), by increasing the
amount of hydroxycinnamic acids produced during fermentation
it allowed to obtain 2.5-fold more curcumin. The amount
produced here was the highest amount of curcumin obtained
from tyrosine to date. The strain-to-strain ratio was also
estimated for both ratios tested (1:2 and 2:1) and it was verified,
for both cases, that at time 0 in M9 the ratio was 33%: 66% which
shows that the strain carrying the first module of the pathway is
clearly in disadvantage and even when it is inoculated in higher
proportion the strain carrying the second module of the pathway
prevailed. Nevertheless, the higher proportion at inoculation
time allowed to produce the proteins needed to obtained higher
production of hydroxycinnamic acids, including ferulic acid that
was converted to curcumin.
The titers herein presented represent 2550 and 6817%
improvements for curcumin and total curcuminoids,
respectively, over the highest titers reported in the literature
to date using an equivalent biosynthetic pathway (Wang et al.,
2015). The productions are also significantly higher than the
ones achieved by Kang et al. (2018), but they used a tyrosine
overproducing strain whereby they are not comparable. In the
future other inoculation ratios can be tested to improve the
productions and/or to favor the production of one curcuminoid
in relation to the others. The use of a co-culture system only
in the M9 phase of fermentation can also be advantageous.
This way the strains will not need to compete in LB when they
are expressing the heterologous proteins and high amounts of
proteins from both modules will be present in the beginning
of the fermentation in M9. In addition, the use of statistical
models to identify optimal expression patterns can be very
useful to in the future improve metabolic pathway efficiency
(Xu et al., 2017).
CONCLUSION
In this work, we successfully designed, constructed and optimized
a heterologous pathway to produce curcuminoids in E. coli.
This biosynthetic pathway includes 6 different enzymes that
catalyze in some cases more than one reaction. One of
these enzymes was COMT that converts caffeic acid to
ferulic acid. We optimized the ferulic acid production from
tyrosine using COMT and 1325.1 µM (257.3 mg/L) of ferulic
acid were produced. In addition, we obtained the highest
curcumin production ever reported in E. coli when ferulic
acid is used as substrate. Around 1529.5 µM (563.4 mg/L)
of curcumin was produced corresponding to a 59.4% increase
compared to previously reported productions. Furthermore,
the curcuminoids production from tyrosine using COMT
was compared to its production using CCoAOMT (which
converts caffeoyl-CoA to feruloyl-CoA) reported in previous
studies. The production of curcuminoids using COMT was
significantly higher than the one using CCoAOMT in the
biosynthetic pathway. Using COMT enzyme in a monoculture
strategy, the production of curcumin increased to 16.6 µM
(6.1 mg/L). Finally, we also used a co-culture strategy to produce
curcuminoids. One E. coli strain was used to produce ferulic
acid from tyrosine, while the other strain converted the ferulic
acid (and/or coumaric acid) produced and released to the
medium to produce curcumin (and/or other curcuminoids).
This strategy allowed to increase the amount of curcumin
(43.2 µM; 15.9 mg/L) and total curcuminoids (125.8 µM;
41.5 mg/L) produced, possibly due to a decreased metabolic
burden to each cell. The productions were very dependent
on the inoculation ratios of the two cultures. To our
knowledge, the productions herein reported are the highest
productions of curcumin/curcuminoids obtained until now.
These results are of interest for all of those working not
only with the heterologous production of curcuminoids, but
also other more complex polyphenolic compounds or plant
secondary metabolites.
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Although the results obtained are very promising, further
improvements can still be made. In the future, this artificial
biosynthetic pathway should be tested using a tyrosine
overproducing E. coli strain to carry the first module. This
strain will be more suitable for an industrial scale since
phenylpropanoic acid substrates are expensive and have low
solubility in aqueous solutions. Moreover, using this strain would
allow to reduce the possible hydroxycinnamic acids toxicity
effects as they will be accumulated in a lesser extent. Future
metabolic optimizations should also include some step(s) to
increase the malonyl-CoA availability that is generally low for
recombinant pathways. The engineering of transporter proteins
to decrease diffusion limitations and increase E. coli tolerance
to hydroxycinnamic acids and curcuminoids leading to a higher
production of this compounds is also of utmost importance.
Finally, to produce pure curcumin from tyrosine or glucose, less
promiscuous enzymes need to be found or the existing ones need
to be further engineered.
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